[
    [
        {
            "time": "",
            "original_text": "华东医药：预计2022年第一季度递交IMGN853生物制品许可申请",
            "features": {
                "keywords": [
                    "IMGN853",
                    "生物制品",
                    "许可申请",
                    "华东医药"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华东医药：预计2022年第一季度递交IMGN853生物制品许可申请",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "华东医药卵巢癌在研新药临床试验效果显著",
            "features": {
                "keywords": [
                    "卵巢癌",
                    "新药",
                    "临床试验",
                    "华东医药"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华东医药卵巢癌在研新药临床试验效果显著",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "华东医药：ADC新药海外关键临床达到主要研究终点 预计明年一季度在美递交生物制品许可申请",
            "features": {
                "keywords": [
                    "ADC新药",
                    "海外临床",
                    "研究终点",
                    "生物制品",
                    "许可申请",
                    "华东医药"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华东医药：ADC新药海外关键临床达到主要研究终点 预计明年一季度在美递交生物制品许可申请",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 10,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "卵巢癌治疗迎突破：全球首款FRα靶点ADC新药有望明年一季度递交美国上市申请",
            "features": {
                "keywords": [
                    "卵巢癌",
                    "FRα靶点",
                    "ADC新药",
                    "上市申请"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "卵巢癌治疗迎突破：全球首款FRα靶点ADC新药有望明年一季度递交美国上市申请",
                "Correlation": 9,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 10,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "华东医药IMGN853海外关键注册临床试验取得积极进展 卵巢癌治疗有望迎来ADC新药",
            "features": {
                "keywords": [
                    "IMGN853",
                    "海外临床",
                    "注册试验",
                    "卵巢癌",
                    "ADC新药",
                    "华东医药"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华东医药IMGN853海外关键注册临床试验取得积极进展 卵巢癌治疗有望迎来ADC新药",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "早间公告：华东医药全资子公司合作研发项目美国临床试验达到主要研究终点",
            "features": {
                "keywords": [
                    "华东医药",
                    "全资子公司",
                    "合作研发",
                    "美国临床",
                    "研究终点"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "早间公告：华东医药全资子公司合作研发项目美国临床试验达到主要研究终点",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]